Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Par Pharmaceutical Companies Inc.
Current Parent Company: Endo International
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $22,500,000
Year: 2013
Date: March 5, 2013
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Violation Description: Par Pharmaceutical agreed to pay $22.5 million to a group of states and the federal government to settle allegations that it promoted its prescription drug Megace ES for uses not approved by the Food and Drug Administration. This was part of a larger $45 million civil and criminal settlement announced by the U.S. Justice Department; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Ireland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.